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Abstract
Background: Genealogy and molecular genetic studies of a Swedish river valley population resulted in a large pedigree,
showing that the hereditary hemochromatosis (HH) HFE/p.C282Y mutation is inherited with other recessive disorders such
as Wilson´s disease (WND), a rare recessive disorder of copper overload. The population also contain individuals with the
Swedish long QT syndrome (LQTS1) founder mutation (KCNQ1/p.Y111C) which in homozygotes causes the Jervell &
Lange Nielsen syndrome (JLNS) and hearing loss (HL).
Aims of the study were to test whether the Swedish long QT founder mutation originated in an ancestral HFE family
and if carriers had an increased risk for hemochromatosis (HH), a treatable disorder. We also aimed to identify the
pathogenic mutation causing the hearing loss disorder segregating in the pedigree.
Methods: LQTS patients were asked about their ancestry and possible origin in a HH family. They were also
offered a predictive testing for the HFE genotype. Church books were screened for families with hearing loss.
One HH family had two members with hearing loss, who underwent molecular genetic analysis of the LQTS
founder mutation, connexin 26 and thereafter exome sequencing. Another family with hearing loss in repeat
generations was also analyzed for connexin 26 and underwent exome sequencing.
Results: Of nine LQTS patients studied, four carried a HFE mutation (two p.C282Y, two p.H63D), none was homozygous.
Three LQTS patients confirmed origin in a female founder ( b 1694, identical to AJ b 1694, a HFE pedigree member from
the Fax river. Her descent of 44 HH families, included also 29 families with hearing loss (HL) suggesting JLNS. Eleven LQTS
probands confirmed origin in a second founder couple (b 1614/1605) in which the woman b 1605 was identical to a HFE
pedigree member from the Fjällsjö river. In her descent there were not only 64 HH, six WND families, one JLNS, but also
48 hearing loss families. Most hearing loss was non syndromic and caused by founder effects of the late 16th century.
One was of Swedish origin carrying the WHRN, c.1977delC, (p.S660Afs*30) mutation, the other was a TMC1(NM_138691),c.
1814T>C,(p.L605P) mutation, possibly of Finnish origin.
(Continued on next page)
* Correspondence: sigvard.olsson@medic.gu.se
1Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska
Academy, University of Göteborg, S 413 45 Göteborg, Sweden
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Olsson et al. Hereditas  (2017) 154:16 
DOI 10.1186/s41065-017-0052-2
(Continued from previous page)
Conclusions: Deep human HFE genealogies show HFE to be associated with other genetic disorders like Wilson´s
disease, LQTS, JLNS, and autosomal recessive hearing loss. Two new homozygous HL mutations in WHRN/p.
S660Afs*30 and TMC1/p.L605P were identified,none of them previously reported from Scandinavia. The rarity
of JLNS was possibly caused by miscarriage or intrauterine death. Most hearing loss (81.7%) was seen after 1844 when
first cousin marriages were permitted. However, only 10 (10.3%) came from 1st cousin unions and only 2 (2.0 %) was
born out of wedlock.
Keywords: Hereditary hemochromatosis, Wilson´s disease, Long QT syndrome, Jervell and Lange- Nielsen´s syndrome,
Non syndromic hearing loss, WHRN, DFNB31, TMC1,
Background
River valley populations of northern Sweden are well
suited for research of monogenic diseases because the
wilderness between them creates sub-isolates [1]. This
usually mean a good breeding ground for autosomal
recessive (AR) diseases like hereditary hemochromatosis
(HH), common in the river valleys of Jämtland [2, 3]. In
this disease, homozygous carriers of the HFE/p.C282Y
mutation have an increased ability to absorb iron due to
reduced levels of hepcidin, the iron regulating hormone
of the liver [4].With time, the iron loading can reach
toxic amounts affecting multiple organs in particular the
liver, but most often the phenotype is mild. The disease
was once regarded rare in Scandinavia and England, pos-
sibly due to widespread iron deficiencies in these coun-
tries [5]. Paradoxically these and other north European
countries today demonstrate the highest mutation fre-
quencies in the world, suggesting selective advantages
[6, 7]. A recent study seemed to indicate that that the
HFE/p.C282Y could segregate other mutations, when
Wilson´s disease (WND), a rare recessive copper loading
disorder [8, 9] appeared in a HH family of the
Swedish west coast. Shortly afterwards this was repeated
in a deep HFE family of the Fjällsjö river in northern
Jämtland [10]. The Swedish long QT syndrome (LQTS)
founder mutation is now reported to originate in this
population [11].
LQTS is an autosomal dominant inherited cardiac
arrhythmic disorder which in homozygotes also causes
hearing loss, and the Jervell and Lange- Nielsen syn-
drome (JLNS) [12], a surprisingly rare disorder, accord-
ing to a recent study by the same authors [13]. By
extensive genealogic investigations the authors were able
to trace individuals carrying the long QT mutation
(KCNQ1/p.Y111C) to common founders, one, a female
born 1694 [14], the other a couple born 1605 and 1614
[11]. The origin and geographic spread of the LQTS mu-
tation, described in detailed maps [11] fascinated us as it
seemed to coincide with the p.C282Y mutation [2] in its
upstream spread into Lapland. This land of 15000 km2
north of N 63.9 was opened for colonization by the
Lapland Bill of 1673, a matter of great relief for expanding
post war populations such as the Fjällsjö (from n = 91 in
1620 to n = 299 in 1751) [15]. As an upstream migration
would most likely result in matches between mutation
carriers and risk for homozygous children [2, 3, 16] we
would expect not only HH but also JLNS along the lines
of descent. Despite a law change in 1844 permitting 1st
cousin unions [17], JLNS was surprisingly rare as only one
(p.Y111C/p.Y111C) afflicted individual have been found
[13]. Singular JLNS subjects have however, been reported
[18] and according to a parish meeting protocol (from
1831) there were families with deaf mute children in the
new habitat [19]. Assuming they may represent his-
toric JLNS, church registries were screened for hear-
ing loss families.
The only way at this time to identify the two LQTS
founder families [11, 14] was to ask systematically LQTS
patients about their ancestry and its possible origin in
hemochromatosis founder families. Like HH patients
[2, 3] LQTS families have been detected and reported
[20] from the county hospital in Östersund and sub-
sequently by other workers (Olof Lövheim and Anders
Gard) at the same hospital.
Aims
The purpose of this study was to find out whether
patients with the Swedish LQTS founder mutation
(KCNQ1/p.Y111C) had an increased risk for HH, by
sharing origin within hemochromatosis (HH) families.
We also aimed to determine the origin and the mo-
lecular genetic background of the hearing loss dis-
order segregating in the pedigree.
Methods
After obtaining permission from their doctors, LQTS pa-
tients from 11 families were contacted and asked about
their ancestry. Before contact they were given written in-
formation about hemochromatosis and the aims of the
study. Hearing loss patients were also contacted and all
consented to an interview, and gave written consent to
blood tests. The study was approved by the Regional
Ethical Review Board at the University of Göteborg,
(Dnr 834/14) ,T 214/16 and T1076-16). Genealogic data
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were extended through information from the genealo-
gists Mr Georg Hansson and Mr Olof Stenum as previ-
ously described [2, 10] and the results were registered in
our hemochromatosis/ Wilson disease database, Holger
7, (http://5493.shop.textalk.se) comprising n = 11076
individuals [10]. Added to the same registry was the an-
cestry of families with deaf or deaf- mute children
detected in church registries by Mr Stenum. During the
interviewing process additional hemochromatosis pa-
tients were identified and added to the registry that now
comprises (n = 13720) individuals. Results were given in
pedigrees drawn manually in Cyrillic 2.1 (Cyrillic Soft-
ware, Old Beaconsfield, UK). In hemochromatosis pa-
tients serum iron, transferrin saturation (TS), serum
ferritin, liver enzymes and HFE mutations were analyzed
as previously described [2]. LQTS patients were tested
for HFE mutations in the LightCycler™ (Roche Diagnostics
Gmbh Mannheim, Germany). Sequencing of the KCNQ1/
p.Y111C LQTS founder mutation was performed at the
laboratory of Clinical Genetics, Umeå University hospital
[14], Umeå, Sweden. Sequencing and multiplex ligation
probe amplification (MLPA) of the GJB2(Cx26) gene was
performed at department of Clinical Genetics, Uppsala
University, Uppsala, Sweden. Whole exome sequencing
was performed by using Ion AmpliSeq™ Exome Library
preparation protocol (Thermo Fisher and sequencing by the
Ion Chef system as described in Bondeson et al [21]. Primer
sequences and PCR conditions for Sanger sequencing of
WHRN (NM_001173425), c.1977delC, (p.S660Afs*30), and
TMC1(NM_138691), c.T1814C,(p.L605P) are available
upon request.
Setting
The study area included the Angerman river and its
tributaries the Fax river and the Fjällsjö river [2, 11]. In
1974 the study area was divided with the upstream par-
ishes Fjällsjö, Bodum and Tåsjö being transferred to the
county of Jämtland. This might have been of importance
because the single county hospital in Östersund happened
to dispose of a laboratory equipment (Autochemist) in-
cluding routine determinations of serum iron and trans-
ferrin saturation (TS) [2, 3]. As an elevated TS is an early
biochemical marker of iron overload [4], this gave us
unique opportunities to detect hemochromatosis.
Results
Three hypotheses were examined
1. The LQTS founders originated in HFE families
1 A. Is the first KCNQ1/Y111C founder, a woman b
1694 [14] identical to A J b 1694? If so she is seen as
V:16 in our Fax river hemochromatosis pedigree,
Additional file 1: Figure S1 [2].
1 B. Is the second founder family b 1614 and 1605
[11] identical to KA b 1614 married to I O b 1605?
If so they are identical to III:1 and III:2 in our Fjällsjö
river hemochromatosis pedigree , (Additional file 1:
Figure S2) [2].
2. If true, there would be a high probability for JLNS
in the descent of 1 A, AJ b 1694 and 1 B, IO b 1605, and
3. An increased risk for hemochromatosis in LQTS
carriers.
1 A. The first KCNQ1/Y111C founder, a woman b
1694 [13] is identical to AJ b 1694, a hemochromatosis
pedigree member of the Fax river [2].
Three LQTS families described an ancestry as shown in
Fig. 1 in agreement with the pedigree described by Winbo
et al in their first study [14]. They shared origin in AJ b
1694, identical to V:16 in our Fax river hemochromatosis
pedigree [2] (see Additional file 1: Figure S1). AJ had
moved in from the Fax river (see family 526 www.5560.se/
familjer/fam-str.pdf to settle new land in Lapland up-
stream in the Fjällsjö river valley in 1732. Her two children
(belonging to different marriages) had a descent who
Fig. 1 Pedigree showing individuals with Long QT Syndrome (LQTS)
and hereditary hemochromatosis (HH). LQTS are marked with half filled
symbols, hemochromatosis with filled blue symbols. Double horisontal
lines mark consanguineous marriages
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married descent members of another pioneer couple b
1727/1729, their closest neighbor living 4 km downstream
the Fjällsjö river. AJ:s daughter II:3 b 1739 died at age
32 from smallpox but had with her husband 6 chil-
dren who survived to reproduce.
1 B. The second KCNQ1/Y111C founder family b
1614 and 1605 [11] is identical to KA b 1614 married
to I O b 1605, a hemochromatosis family member of
the Fjällsjö river [2].
Eleven long QT families including the three of Fig. 1
revealed that they all originated in a founder family born
1614/1605 identical to III:1 and III:2 of our Fjällsjö river
HFE-pedigree (Additional file 1: Figure S2) [2]. These
findings shown in Fig. 2 agree well with the Winbo et al
pedigree /Fig. 3/ [11] supporting our second hypothesis.
The first LQTS founder AJ b 1694 is seen as IV:1 and
the 1727/1729 family of Fig. 1 now appears as V:3-4 and
is identical to V:5 in the Winbo et al pedigree /Fig. 3/
[11], which connected 10 (38.4%) of the 26 long QT
families. Repeated consanguineous marriages were seen,
however without hearing loss other than in XII:12. The
degree of coinheritance with HFE/p.C282Y was sub-
stantial but involved only the upstream migration
while the downstream descent from II:3 seemed un-
affected by the p.C282Y.
2 A. Hearing loss suggesting JLNS in the descent of
a LQTS founder b 1694 [14].
The descent of the first founder AJ b 1694 comprised
25 A4 pages in agreement with a high reproduction and
a high frequency of HH families (n = 49). For clarity
these were excluded in the pedigree of Fig. 3, which
contained not only four 4 LQTS families, but also 29
families with deaf mute children suggesting JLNS.
Phenotypic expression other than hearing loss was most
often mild and sudden death was rarely reported.
2 B. Hearing loss suggesting JLNS in the descent of
the LQTS 1605/1614 founder family.
The descent of the second founder family comprised
106 A4 pages and was difficult to illustrate in Cyrillic,
mainly due to the high number of HH families (n = 64),
of whom 35 (55%) were in common with the first
founder AJ. There were also six WND families [10] and
48 families with hearing loss of whom 15 were in com-
mon with the first founder. A simplified pedigree is seen
in Fig. 4 including a 1st cousin marriage (III:1-III:2) and
the descent from one (IV:1) of their 11 children. In her
descent was the D 9 family with a nine year old daughter
who died on the 4th of October 1839 ‘af slag, döfstum’ =
(from stroke, deaf- mute). This was shortly after her
mother´s death, aged 33, during her 5th childbirth on
14th of September 1839. As emotional stress may initiate
serious arrhythmic events, this might have been the
background of the “stroke”. The mother had lost another
stillbirth and also three other children, of whom two
died within their first three days of life. The parents of
the 9 year old girl were only distantly related to the
LQTS 1605/1614 founder II family.
The D 24 family was of interest because of the two
deaf mute siblings XII:18 and XII:21were still alive in
2014 and available for a molecular genetic evaluation.
Their two brothers with HH , XII:22 and XII:23 had
been previously reported as homozygous carriers of the
HLA A3B7 haplotype [2], (See: S2 XIII:43-44, down
right arrow) suggesting a common origin. In support of
a possible JLNS was the sudden death of their brother
XII:19 at age 14 (stroke of lightning) and a record from
1967 when the oldest brother XII:18, was observed at
hospital after fainting. An ECG showed however, nor-
mal QT duration and a subsequent test negative for
the KCNQ1/p.Y111C mutation excluded the possibility
of JLNS.
Mutation analysis of the GJB2 gene encoding connexin
26, did not reveal any mutations in families D 24, D 86
and D 87 thus excluding DFNB1, the most common
form of autosomal recessive HL. Exome sequencing of
XII:18 and XII: 21 (Fig. 4) following a recessive filtering
towards an in-house database (consisting of 1400 ethic-
ally matched controls) and publicly available database
revealed an interesting finding .One novel homozygous
variant, c.1977delC,(p.S660Afs*30) in the WHRN gene
(also denoted DFNB31) (NM_001173425),was found
which, encodes the whirlin protein. Mutations in WHRN
have previously been shown to cause autosomal recessive
non syndromic deafness [22] and Usher syndrome type
2D [23]. The novel variant c.1977delC,(p.S660Afs*30) was
considererd to be pathogenic since it results in a frame-
Fig. 2 Pedigree connecting families with LQTS and HH to a common
founder couple b 1614/1605. IV:1 is identical to AJ b 1694 from Fig. 1
and V:3-V4 b 1729 /1727 were her neighbors . Double heterozygotes
(LQT/HFE) are marked by lower arrows. XII:12 ,marked by a lower left
arrow, had a hearing aid at age 42. Symbols as in Fig. 1
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shift, and is present in homozygous form in the fam-
ily and the normal population frequency is very low.
Segregation analysis of the p.S660Afs*30 was per-
formed in D 86 and in XII:16 of the D 87 family,
and none of the individuals investigated carried the
mutation.
In the D87 family exome sequencing was performed
of the two unrelated HL parents XII:16 and XII:15
(from a distant river valley), and the youngest of their
three deaf mute children, XIII:12, following a reces-
sive filtering as described above. All family members
were homozygous for a novel missense variant in the
TMC1 gene c.T1814C,(p.L605P), (NM_138691). Mutations
in the TMC1 gene are causing autosomal recessive HL [24]
and is one of the most commonly mutated genes in the
Western-European population [25]. The variant
c.1814C,(p.L605P) was considered to be likely pathogenic
since it is present in extremely low frequency in the normal
population and is located in the TMC domain. There are
multiple lines of computational evidence that support a
deleterious effect and it is present in homozygous form in
the family. The TMC1 mutation was not identified in D 24
and D 86 supporting the presence of at least two different
HL mutations in the population. The hearing loss in D 86,
was most probably caused by his mother´s rubeola
infection.
Fig. 3 Pedigree showing individuals with hearing loss marked with filled yellow symbols with a short lower arrow (suspected Jervell & Lange-Nielsen
Syndrome). LQTS as in Fig. 1. Admixture from an outside origin is marked with filled red symbols
Fig. 4 Pedigree showing families with LQTS and hearing loss (suspected Jervell and Lange Nielsen syndrome (JLNS). D 9 was deaf-mute and died
of stroke at age 9 suggesting JLNS. The pedigree also show connection to a hemochromatosis founder family born 1580 in which three HL families
D 87, D 24 and D 86 were available for molecular genetic evaluation. The D 24 parents were 3rd cousins once removed from a marriage 1788 marked
with a vertical arrow. The LQTS founder II family is marked by a left upper arrow. Symbols as in Fig. 2
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Origin of mutations
Parents of the D 24 family with the WHRN/p.S660Afs*30
mutation were 3rd cousins once removed from a remote
consanguineous marriage in 1778 marked by an arrow in
Fig. 4. Further extension revealed a possible founder origin
in a family of the late 16th century from village K in the
parish of Anundsjö. This founder family seen in Fig. 5 had
a descent with similarly affected HL families living in the
parish. The VI:1-2 family (family size 14, effective family
size 6) had members who migrated into the new habitat.
They are recognized in the pedigree of Fig. 3 (marked in
red). The village K family (comprising 139 A4 pages) had
a total of 60 HL families in its descent (data not shown),
but the D 87 was not included suggesting a different ori-
gin of that mutation.
The mother of the D 87 family, homozygous for the
TMC1/L605P mutation, originated from a consanguin-
eous marriage in which both parents shared origin in a
HL family of the late 18th century as seen in Fig. 6. Fur-
ther extension revealed a common origin in a Finnish
migrant family of the late 16th century. Their descent is
seen in Fig. 7 connecting 68 HL families (of whom 54
were in common with the village K family). Although
extensive, the pedigree is incomplete because for clarity,
nine WND families, seven LQTS and 75 HFE families
had to be excluded. Most hearing loss families (81.4%)
were seen after 1844 when first cousin marriages were
permitted. However, only 10 (10,3 %) came from 1st
cousin unions, there were 11 (11.7%) of 2nd cousins, 16
(17.0 %) 3rd and 5 (5.3 %) 4th cousins. A remote consan-
guinity was present in 18(19.1 %). Only 2 (3.6 %) were
born out of wedlock.
3. LQTS patients carrying HFE mutations.
Nine LQTS patients were available for a HFE genotype
test, two carried p.C282Y, two p.H63D and five were
without HFE mutations. None was homozygous.
Electrocardiograms have not been rechecked in all of
HH probands, only in those with a history of arrhythmia.
None was found to have prolonged QT duration. One
retested was a 43 year old male in the descent of LQTS
founder II family who had serious arrhythmic events
needing implantable cardioverter defibrillator (ICD)
treatment. He had normal hearing and normal QT inter-
vals but had a severe HH phenotype (to be published).
Discussion
In the present study we could verify the first and second
hypotheses but not the third. The genealogic studies
suggest that the Swedish LQTS founder mutation
KCNQ1/p.Y111C [11, 14] shared an origin and segre-
gated with the HFE mutation [2] in a river valley popula-
tion of northern Sweden (Figs 1, 2, and 3 and Additional
file 1: Figure S1 and Figure S2) . It is known that genetic
material with potentially modifying properties may co-
segregate with the deleterious mutation [11], however,
there is little evidence to support iron or HFE mutations
[26, 27], as contributing factors to the mild phenotype
seen in the Swedish LQTS families [11, 14]. The map
findings of LQTS upstream the river [11] are fascinating,
not only for corresponding with HFE, but also for the
hearing loss families along the same pathways. Such
families existed in the new habitat because a parish
meeting protocol (of 1831) informed that “deaf mute
children at age 11 to 14 years had a chance of a free
Fig. 5 Pedigree of the D 24 family presenting the origin and segregation of the p.S660Afs*30 mutation of the WHRN DFNB31gene. Two siblings
from a marriage in 1778 (arrow) may have introduced the mutation by co migration with the HFE mutation (in blue). A founder effect of the late
16th century seems likely. VI:1-2 is equal to II:5-6 of Fig. 3
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place at a hearing institute” [19]. There would be a high
probability for KCNQ1/p.Y111C homozygosity and JLNS
[13], because of a preference of LQTS mutation carriers
to marry within the same river valley [1, 11, 14] and also
because first cousin unions were no longer prohibited by
law. This law change in 1844 had been shown to have a
major influence on hereditary diseases in northern
Sweden [17]. The consanguineous marriages shown in
Fig. 1 and the findings of 29 hearing loss families shown
in Fig. 3, was therefore not surprising. They could well
represent JLNS, but against such a diagnosis was a
phenotype in which sudden death was rarely reported.
Similar observations were made in the descent of the
second LQTS founder (Fig. 4) with one exception, the D
9 family, which was severely affected and may well rep-
resent JLNS. Three other individuals afflicted with JLNS
from the same hospital [18] may belong to this founder
family of Fig. 4. It is possible that homozygous pregnan-
cies were selected against resulting in early abortion or
intrauterine death of their outcome [13]. As we have
found such families to occur, and also families with mul-
tiple miscarriages, this may explain the rarity of JLNS.
Surprising was the rarity of JLNS in inbred LQTS
families with repeat consanguineous marriages seen in
Fig. 2. However, homozygous carriers without hearing
loss have been known since 1998 [28] and may con-
tain a 10% residual KCNQ1 function that rescues
hearing [29]. In such high-risk families fetal heart rate
observations have been helpful to predict the pheno-
type in LQTS [30].
Origin and nature of non syndromic hearing loss detected
by exome sequencing
The genetic tests of the D 24 family excluded the JLNS
and DFNB1 because screening of the LQTS KCNQ1/
p.Y111C and GJB2 did not reveal homozygous or com-
pound heterozygous mutations [31]. However , exome
sequencing revealed the presence of a mutation WHRN/
p.S660Afs*30 at the DFNB31 locus [22].This mutation
was possibly introduced in a marriage of 1778 seen as
VI:15-16 of Fig. 4 (marked by an arrow). Further genea-
logic studies supported the presence of a local founder
effect with hearing loss families connected through con-
sanguineous marriages in the parish of Anundsjö as
shown in Fig. 5. There was a considerable spread of the
supposed WHRN gene from the founder family into the
new habitat and the VI:1-2 of Fig. 5 is an example with a
Fig. 6 Pedigree showing the ancestry of the D 87 family with
homozygosity for the TMC1/p.L605P in repeat generations. Both
parents of XIII:2 share origin in a generation VIII family with hearing
loss. The first HL member observed (on the 23rd of December 1715
(44) is seen as IV:16. IV:18 is the “Finnkommissioner” of the HFE
family marrying into the Finnish founder family. Finnish ancestry
is marked with light blue symbols
Fig. 7 A pedigree connecting 68 hearing loss families including the D 87 family with the TMC1/p.L605P mutation to the common founder of Fig. 6.
The first documented hearing loss individual (MP b 1655), is marked by an upper arrow and the “Finncommisioner” with a lower arrow
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significant effect (marked in red) upon the pedigree
of Fig. 3. The DFNB31 locus was first identified in a
Palestinian family living in Jordan [22] and in a
Tunisian kindred [32], but is not a common cause of
hearing loss [22].
We were surprised that the D87 family, with hearing
loss in successive generations [18], lacked the WHRN/
S660Afs*30 mutation. However, exome sequencing of
the two HL parents and one of their three HL children
showed all three to be homozygous for TMC1/p.L605P.
The TMC1 gene has previously been reported to cause
autosomal recessive hearing loss [24]. Like WHRN, it is
also reported from Tunisia [33] and Morocco [34], but
also from Western [25] and Eastern [35] Europe. Exten-
sive genealogic studies seen in Figs. 6 and 7 now support
a possible Finnish founder origin. This vast pedigree and
the pedigree of Fig. 5 may well explain most of the hear-
ing loss of previous pedigrees, Figs. 3 and 4.
We can not exclude the possibility of single cases be-
ing caused by environmental factors such as infections,
(rubeola and cytomegalovirus) . Nor can we exclude HL
cases for being misclassified as feeble-minded in the
church records. Previous reports of hearing loss in
Sweden showed the highest figure, (13/10000) in the
county of Västerbotten [36], almost identical to the
figures from Finland , the highest in Europe [37].
More recent studies (81) support the high Västerbotten
figures and the HL findings of Fig. 7 may be seen as
a background.
Somewhat remarkable were the present findings of a
deep HFE genealogy [2] upstream a Swedish river val-
ley segregating with Wilson´s disease [10] and LQTS
[11, 14] was also segregating with hearing loss caused
by mutations in WHRN and TMC1 respectively.
The HFE mutation has, despite its young age, reached
surprisingly high frequencies in North European iron
poor areas [2–4, 6, 7] as predicted by Motulsky [38].
The lack of hepcidin giving homozygotes an increased
capacity to absorb iron [4] might have been of selective
advantage in an iron poor environment like the present
Swedish ones [2, 39]. Whether the immune response
genes in their HLA has contributed is hard to prove, but
the haplotypes, A1B8 of the Fax river and A3B7 of the
Fjällsjö river [2] are both very common, showing a strik-
ing relationship with HFE/p.C282Y through Europe [6].
A possible explanation to a selective advantages of
HFE , LQTS and TMC1 is their presence in early colo-
nizers (Figs. 1-4, 6-7 ) of the new Lapland habitat. As
compared to individuals in the wake, the pioneers at a
colonization front are said to be much more successful
in passing their genes on to future generations through a
mechanism of gene surfing [40]. Whether such a factor
might have influenced the spread of the WHRN muta-
tion seen in Fig. 5 is unclear. The family VI:1-2 of this
pedigree consisted of 14 siblings of whom six (all
females) reproduced, equal to an effective family size
(EFS) of six. Three stayed and married in the local parish
and got children with an average EFS of two (4+1+1),
while three migrated into the new habitat and married
colonizers (marked in red of Fig. 3). They got an average
EFS of 7.7 (6+8+9) suggesting selective advantages.
However, their success might also have been influenced
by their marriage partners of past Finnish origin, from
the first colonizers of Lapland well described by Richard
Gothe [41]. Extensive genealogic studies seen in Figs. 6
and 7, suggest a possible Finnish origin of the TMC1
mutation. The founder AI A was born about 1570 in
Äänekoski, a parish of central Finland. Our findings may
be questioned because TMC1 has not been found among
6612 Finnish alleles tested in the Exome Aggregation
(ExAC) database [42] in which 5 TMC1 alleles were
found from Europe. However, our findings may be sup-
ported by the Finnish deaf mute statistics of 1912
(revised by Björkquist 1916 [43]) in which the parish
of Äänekoski reported 11 (corresponding to 19/10000)
HL individuals.
The first document of hearing loss in the new habitat
is from an inspection of the church in Arsilla = Åsele in
1715 [44]. On the 23rd of December 1715 the inspector
arrives in Hällan, the first village in Lapland at which he
had to spend the night in the house of a colonizer who
was “dumbe”= deaf mute. The next day he passes the
village Gafsele and the house of the “Finncommissioner”
until arrival in Åsele. There is genealogic evidence that
the colonizer b 1655 is identical to IV:16 of Fig. 6 and
the “Finncommissioner” identical to IV:18. The two are
marked with arrows in Fig. 7.
Selective advantages was recently demonstrated in a
similar upstream isolate of the Saguenay river, (SLSJ), of
Quebec, Canada, in which deep human genealogies re-
vealed a selective advantage to those on an expanding
wave front [45]. The genetic footprints of these pioneers
are still recognizable, and the HLA-A3B7 haplotype of
the D 24 HFE family, also present in (SLSJ) [46], was
recently attracted attention because of its presence in an
Irish skeleton of the bronze age [47].
It may seem strange that a founder common to
one disease (HH) is a common founder also of an-
other disease. However this is not uncommon ac-
cording to lessons from Quebec [48]. The findings
of Hereditary hemochromatosis [2], Wilsons disease
[10], LQTS [11, 14], and Hereditary hearing loss in
the present study is therefore not unique.
Our pedigrees are small in number compared to the
great French Canadian (SLSJ) findings [48], however this
may be explained by the harder environmental condi-
tions in Sweden north of N 63.9. While the upstream
SLSJ today have a population of about 300.000 [48] less
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than 15000 live in the Swedish habitat (n = 12396,
Statistics Sweden 2015).
One simple explanation for the survival and multipli-
cation of the HFE mutation is its often mild phenotypic
expression in homozygotes [49]. Even in those with a se-
vere phenotype this comes late and does not interfere
with reproduction. Two previous studies have been unable
to prove reproductive advantage in hemochromatosis fam-
ilies [50, 51]. Whether the same would be seen in an iron
poor environment as the present [2–4, 39], is unknown.
Somewhat surprising was the low frequency (22.2%) of
HFE alleles (two p. C282Y, two p.H63D) in LQTS car-
riers. None was homozygous or showed compound
heterozygosity.
Finally, recent studies using exome sequencing have
shown that individuals can carry multiple recessive mu-
tations as demonstrated in the Hutterites population
[52]. In their study, some individuals could carry up to 5
recessive mutations and some could be homozygous for
3 different mutations . Our findings of two new recessive
hearing loss mutations segregating with HFE [2], WND
[10] and LQTS [11, 14] is therefore not remarkable,
and is possible to reveal due to new technology now
available.
Even if genealogic studies may be fascinating they are
also time consuming. We would therefore recommend
the use of information already assembled in genealogic
registries. It is likely that some of the remaining 30% of
the LQTS probands could have been attached [11]. Even
if we agree that all blood lines are not conceived within
wedlock [11], recent studies using Y-chromosome and
genealogical data, have shown low historical rates of
cuckoldry [53].
Conclusions
Deep human HFE genealogies show HFE to be associ-
ated with other genetic disorders like Wilson´s disease,
LQTS, JLNS, and autosomal recessive hearing loss. Two
new homozygous HL mutations in WHRN/p.S660Afs*30
and TMC1/p.L605P were identified,none of them previ-
ously reported from Scandinavia. The rarity of JLNS was
possibly caused by miscarriage or intrauterine death.
Most hearing loss (81.7%) was seen after 1844 when first
cousin marriages were permitted. However, only 10
(10.3%) came from 1st cousin unions and only 2 (2.0 %)
was born out of wedlock.
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